Triệu, Nguyễn Thị, M.D. Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2009
NCT02618148
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Trieu, Nguyen Thi, M.D. | Triệu, Nguyễn Thị, M.D.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leiomyoma (Phase 4)

Myofibroma (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 14